The journal retracts the August 06 2024 article cited above.

Following publication, concerns were raised regarding the scientific validity of the article. An investigation was conducted in accordance with Frontiers’ policies.

It was found that the complaints were valid and that the article does not meet the standards of editorial and scientific soundness for Frontiers in Endocrinology; therefore, the article has been retracted.

This retraction was approved by the Chief Editors of Frontiers in Endocrinology and the Chief Executive Editor of Frontiers. The authors did not provide a response to this Retraction.

Citation: Frontiers Editorial Office (2025) Retraction: Mendelian randomization based on immune cells in diabetic nephropathy. Front. Endocrinol. 16:1575593. doi: 10.3389/fendo.2025.1575593

Received: 12 February 2025; Accepted: 12 February 2025;
Published: 19 February 2025.

Copyright © 2025 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==